Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 303 clinical trials
Study to Compare Efficacy and Safety of LUBT010 and Lucentis in Patients With Neovascular AMD

This study is designed to compare the efficacy, safety and immunogenicity of LUBT010 with Lucentis given as once monthly intravitreal injection in patients with neovascular age-related macular

  • 0 views
  • 15 Mar, 2021
  • 26 locations
An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

The purpose of this extension study is to evaluate the efficacy and safety of brolucizumab used in a Treat-to-Control-regimen for treatment of patients with neovascular age-related macular

  • 0 views
  • 30 May, 2021
  • 47 locations
Do Blue-Blocking Lenses Block Blue Colour From Our Lives?

To measure colour vision in patients with a blue light filtering lens implant in one eye and non-tinted implant in the other eye (and compared this group with a control group with bilateral non-tinted implants) and to determine whether blue light filtering lenses limit colour vision

lens implant
cataract
  • 13 views
  • 07 Nov, 2020
  • 1 location
Intraoperative Analysis of the Central Retina in ERF

Changes in the retinal anatomy that occur in epiretinal fibrosis have not been sufficiently studied. It is possible that epiretinal fibrosis leads not only to traction dislocation of the macula, but also to ILM anatomical disorders.

  • 0 views
  • 27 Mar, 2021
  • 1 location
Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

This phase II trial studies how well stereotactic body radiation therapy and aflibercept work in treating patients with uveal melanoma. Stereotactic body radiation therapy is a specialized radiation therapy that sends x-rays directly to the tumor using smaller doses over several days and may cause less damage to normal tissue. …

  • 0 views
  • 27 Jan, 2021
  • 1 location
25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial

Proliferative diabetic retinopathy(PDR) is the leading cause of visual loss in diabetic patients. Operation is an efficient method to treat PDR. Anti-vascular endothelial growth factor (anti-VEGF) can be used as an adjuvant therapy which can make operation more easy.

vegf
detachment
diabetes
adjuvant therapy
vascular endothelial growth factor
  • 5 views
  • 22 Jan, 2021
  • 1 location
A Comparison of Visual Functions and Side-effects After DSAEK or DMEK for Fuchs' Endothelial Dystrophy

Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's membrane endothelial keratoplasty (DMEK) are becoming increasingly popular as treatments for Fuchs' endothelial dystrophy. However, despite several years of use the incidence of cystoid macular edema and damage related to increased intraocular pressure (IOP), and the forward scattering of light through the …

intraocular pressure
endothelial keratoplasty
corneal transplant
cataract
edema
  • 0 views
  • 26 Jan, 2021
  • 1 location
  • 0 views
  • 11 Jun, 2021
  • 27 locations
  • 57 views
  • 13 Jun, 2021
  • 20 locations
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial

The Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) Trial will compare the relative efficacy and safety of intravitreal methotrexate, intravitreal ranibizumab, and the intravitreal dexamethasone implant for the treatment of uveitic macular edema persisting or reoccurring after an intravitreal corticosteroid injection. MERIT is a parallel design (1:1:1), randomized comparative …

panuveitis
triamcinolone
cysts
corrected visual acuity
dexamethasone intravitreal implant
  • 324 views
  • 25 Jan, 2021
  • 31 locations